
Marvel Biosciences Corp.
Marvel Biosciences Corp. (MRVL.V) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MRVL.V · as of Jun 8, 2026
Key Statistics
Explore Marvel Biosciences Corp. Data
mrvl.v stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
mrvl.v competitorsStock Performance
Full HistoryAbout Marvel Biosciences Corp.
Marvel Biosciences Corp. operates as a pre-clinical stage pharmaceutical development biotechnology company. It engages in the discovery and development of synthetic derivative compounds of known drugs…
what is marvel biosciences corp. · mrvl.v stock overview · marvel biosciences corp. company profile · who is marvel biosciences corp. ceo · mrvl.v TSXV · marvel biosciences corp. headquarters · marvel biosciences corp. business segments
About Stock Overview & Key Data
Marvel Biosciences Corp. (MRVL.V) is a Healthcare company in the Biotechnology industry, listed on TSXV since Jul 13, 2021. As of the latest trading session, MRVL.V stock price is $0.24, with a market capitalization of $15.1M. The stock has returned +140.00% over the past 12 months and +77.78% year-to-date.
In fiscal year 2025, Marvel Biosciences Corp. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Marvel Biosciences Corp. (MRVL.V) stock price is $0.24. The stock is traded on TSXV under the ticker symbol MRVL.V. The 52-week range is $0.09 – $0.40.